MichaelJamesMorrisMD

Pulmonology • Fort Sam Houston, TX

Physician

Join to view full profile

Dr. Morris is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Morris' full profile

Already have an account?

Office
3551 Roger Brooke Dr
Fort Sam Houston, TX 78234
Phone+1 210-916-3027

Fax+1 210-916-5187

Education & Training

San Antonio Uniformed Services Health Education ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 1992 - 1995
San Antonio Uniformed Services Health Education ConsortiumResidency, Internal Medicine, 1987 - 1990
Eastern Virginia Medical SchoolClass of 1987

Certifications & Licensure

TX State Medical License 1998 - 2026
MS State Medical License 2017 - 2024
American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

2 citations
Exercise capacity remains supernormal, though mildly reduced in middle-aged military personnel with Moderate to Severe Obstructive Sleep Apnea.
Subodh K Arora, Tyler A Powell, Shannon N Foster, Shana L Hansen, Michael J Morris
Sleep & Breathing = Schlaf & Atmung. 2023-03-01
9 citations
Consensus Statements on Deployment-Related Respiratory Disease, Inclusive of Constrictive Bronchiolitis: A Modified Delphi Study.
Michael J Falvo, Anays M Sotolongo, John J Osterholzer, Michelle W Robertson, Ella A Kazerooni
Chest. 2023-03-01
10 citations
Volumetric characteristics of idiopathic pulmonary fibrosis lungs: computational analyses of high-resolution computed tomography images of lung lobes
Bora Sul, Lucia Flors, Joanne Cassani, Michael J. Morris, Jaques Reifman
Respiratory Research. 2019-10-11

Press Mentions

Lung Cancer Spit Test Fast-Tracks a San Antonio Biotech Company for GrowthOctober 12th, 2024
bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung TestOctober 9th, 2024
Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-up, Medical Complications and OverdiagnosisSeptember 18th, 2024